International Faculty

Samuel Asirvatham

Samuel J. Asirvatham, M.D., is a cardiac electrophysiology consultant in the Division of Heart Rhythm Services, Department of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota. Dr. Asirvatham holds joint appointments in the Division of Pediatric Cardiology, the Department of Physiology and Biomedical Engineering, and the Department of Anatomy. In addition, he serves as vice chair for innovation in the Department of Cardiovascular Medicine and medical director of the Electrophysiology Laboratory. He joined the staff of Mayo Clinic in 2000 and holds the academic rank of professor of medicine and pediatrics, Mayo Clinic College of Medicine and Science. Dr. Asirvatham is recognized with the distinction of the James M. and Lee S. Vann Professorship in Cardiovascular Diseases.

Aaron Baggish

Dr. Aaron L. Baggish is the founder and Emeritus Director of the Cardiovascular Performance Program (CPP) at the Massachusetts General Hospital in Boston, MA, USA. The CPP, an affiliate of Harvard Medical School, was the United States’ first program designed to provide comprehensive cardiovascular care to elite and recreational athletes. He is now professor of medicine at the University of Lausanne’s Institut des sciences du sport (ISSUL) and chief of sports cardiology at the Centre Hospitalier Universitaire Vaudois (CHUV). Dr. Baggish is currently a fellow of the American College of Cardiology and a fellow and Board of Trustees member of American College of Sports Medicine.

Dr. Baggish’s research interests include exercise-induced cardiac remodeling, pre-participation screening / sudden death prevention, high performance physiology, performance enhancing substance use, and exercise dose and clinical outcomes. He has received research funding from the National Institutes of Health, the US Department of Defense, the American College of Sports Medicine, the American Medical Society for Sports Medicine, and the NFL Players Association. He has published more than 300 original peer reviewed research articles and numerous invited reviews, editorials, and book chapters and serves on the editorial boards of multiple journals including Circulation and Medicine & Science in Sports and Exercise.

Jeroen Bax

ESC Immediate Past-President (2018 – 2020), Jeroen Bax is Director of non-invasive imaging and Director of the echo-lab at the Leiden University Medical Center, The Netherlands. His main interests include clinical cardiology, heart valve disease, heart failure, cardiac resynchronization therapy and the application of all different imaging modalities to these clinical fields. Professor Bax has authored numerous papers and holds several positions in national and international scientific organizations, as well as serving on the editorial boards of many different journals.

Merri Bremer

Merri L. Bremer, Ed.D., RN, ACS, RDCS, FASE, AACC is the Mayo Clinic Echocardiography Laboratory Education and Quality Coordinator and Advanced Cardiovascular Sonography (ACS) Program Director.  She is an Assistant Professor of Medicine in the Mayo Clinic College of Medicine and holds a doctoral degree in Educational Leadership. Dr. Bremer is an active member of the American Society of Echocardiography (ASE) and the Society of Diagnostic Medical Sonography (SDMS), and is Immediate Past-Chair of the Intersocietal Accreditation Commission (IAC) Board of Directors. She participates in ultrasound program accreditation through the Joint Review Committee on Education in Diagnostic Medical Sonography (JRC-DMS) and is a member of the Cardiovascular Credentialing, Intl (CCI) ACS Credentialing Exam Committee. During the past 30 years, Dr. Bremer has lectured extensively on various echocardiography topics, education, sonographer ergonomics, quality improvement, and accreditation; in addition, she has co-authored several publications.

Matt Budoff

Matthew Jay Budoff, MD, FACC, FAHA, is a professor of medicine at David Geffen School of Medicine at UCLA and the Endowed Chair of Preventive Cardiology at Harbor-UCLA Medical Center. Dr. Budoff is a graduate of University of California at Riverside (BS) and graduated a member of Alpha Omega Alpha from George Washington University School of Medicine (MD).

Dr. Budoff has author or coauthored more than 50 books and book chapters and more than 1000 articles. He has received numerous research grants from the National Institutes of Health. In addition to his 2015 appointment as the Endowed Chair of Preventive Cardiology at Harbor-UCLA Medical Center, he has been recognized for his work by the Society of Cardiovascular Computed Tomography, from which he received the Gold Medal Award and recently designated as Master of the Society of Cardiovascular Computed Tomography (MSCCT). 

Bernard Gersh

Professor of Medicine at Mayo Clinic College of Medicine, Consultant in Cardiovascular Diseases and Internal Medicine. Dr. Gersh received his MB, ChB, from the University of Cape Town in South Africa and received his Doctor of Philosophy degree from Oxford University where he was a Rhodes Scholar. He received the degree of Ph.D. (honoris causa) from The University of Coimbra, Portugal in 2005.

Dr Gersh has approximately 1321 publications (1172 manuscripts and 149 book chapters) (h-index 151). In 2014 and 2015, was named in the Thomson Reuters list of individuals with the greatest number of cited scientific papers 2002-2012. Dr. Gersh is the editor of 15 books and is on the editorial board of approximately 20 peer review journals.

He is an Honorary Professor of Medicine at the University of Cape Town, South Africa, and an Adjunct Professor in the Department of Medicine at Duke University School of Medicine. In 2019, Dr. Gersh was appointed as an Honorary Clinical Professor in the Centre for Clinical Pharmacology, William Harvey Research Institute, Queen Mary University in London.

Dr Gersh has received multiple awards from the American Heart Association (Distinguished Scientist Award), the American College of Cardiology, the European Society of Cardiology (Gold Medal), the Mayo Clinic, University College, London, and the University of Cape Town.

Dr Gersh received the degree of Ph.D. (honoris causa) from The University of Coimbra, Portugal in 2005. At ESC in 2013, he was designated as one of four “legends of modern cardiology”. In 2020, he was named as a highly cited researcher by Web of Science.

Martha Gulati

Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC is the President of the American Society for Preventive Cardiology. She recently joined the Cedars-Sinai Heart Institute as a professor of cardiology and is the director of prevention, the associate director of the Barbra Streisand Women's Heart Center and holds the Anita Dann Friedman Endowed Chair in Women’s Cardiovascular Medicine and Research. She was a professor of medicine and the inaugural Chief of Cardiology at the University of Arizona. She also served as editor-in-chief of CardioSmart, the patient education arm of the American College of Cardiology. She is the author of the best-seller, “Saving Women’s Hearts”. She served as the chair of the national chest pain guidelines from the American Heart Association and the American College of Cardiology, that were released in 2021.

Her exceptional commitment to the study of women and cardiac diseases has won her numerous awards and distinctions, including being named by Crain’s Chicago Business as one of Chicago’s Top 40 under 40. In 2011, she received the first CREDO (Coalition to Reduce Racial and Ethnic Disparities in Cardiovascular Outcomes) Award from the American College of Cardiology that was given to honor her contributions to improve cardiovascular healthcare of women patients. In 2012, she was awarded the National Red Dress Award for her efforts in raising awareness of heart disease in women and advancing research in this field. In 2019, she was chosen as the most influential woman in Arizona and received the 2019 American College of Cardiology’s Bernadine Healy Award for her leadership and accomplishment in the field of cardiovascular disease in women.

She is the principal investigator of the St. James Women Take Heart Project, a study that examined cardiac risk factors in women, which set standards for women’s fitness levels and heart rate response to exercise.  She is the site PI and coinvestigator of the WARRIOR (Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD) trial that is funded by the Department of Defense. She also is a co-investigator on the Women Ischemic Syndrome Evaluation (WISE) study and previously served as a co-investigator on the Women’s Health Initiative (WHI).  She has published articles in peer-reviewed publications, including The New England Journal of Medicine, Circulation, and Journal of the American Medical Association (JAMA).  She has also been featured on Oprah.

Dr. Gulati is Canadian and completed medical school at the University of Toronto, Canada.  She went on to complete her internship, residency and cardiology fellowship at the University of Chicago.  She received a Masters’ in Science at the University of Chicago and is a fellow of the American College of Cardiology, the American Heart Association, the American Society for Preventive Cardiology & the European Society of Cardiology.  She is board certified in cardiovascular disease.

Michael Mack

Michael J. Mack, M.D. Dr. Mack has practiced cardiothoracic surgery in Dallas, TX since 1982.  He is board certified in Internal Medicine, General Surgery, and Thoracic Surgery and has over 900 peer reviewed publications.

Dr. Mack was President of the Society of Thoracic Surgeons (STS) 2011 and is Past President of the Thoracic Surgery Foundation for Research and Education (TSFRE) 2009-2011, the Southern Thoracic Surgical Association (STSA) 2009 and the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2000. He is also a past member of the American College of Cardiology Board of Trustees, Nominating Committee, and Governance Committee and is the past Co-Chair of the STS/ACC National Transcatheter Valve Therapy (TVT) Registry and TVT Stakeholder Advisory Group.

He is a Master of the ACC and is an honorary member of the German Society for Thoracic and Cardiovascular Surgery, the Indian Association of Cardiovascular and Thoracic Surgery, Mexican Society of Cardiac Surgery and is the recipient of the Presidential Citation of the American College of Cardiology, the Transcatheter Cardiovascular Therapeutics (TCT) Lifetime Achievement Award and the 2022 American Association for Thoracic Surgery (AATS) Lifetime Achievement Award. 

Rekha Mankad

Dr. Rekha Mankad M.D, FACC, FASE, is an Assistant Professor of Medicine in the division of Cardiovascular Diseases and the Director of the Cardiorheumatology Clinic and the Women’s Heart Clinic at Mayo Clinic in Rochester, MN. In addition, she is the Co-Director of Education for the division of cardiac ultrasound.

Vivek Muthurangu

Vivek Muthurangu is Professor of Cardiovascular Imaging and Physics at UCL ICS. He is also the Head of the Research Department of Children’s Cardiovascular Disease which incorporates all ICS researchers based at Great Ormond Street Hospital (GOSH). As lead for the Centre of Translational Cardiovascular Imaging, he has established a team of physicists, engineers, computer scientists and clinicians that have pioneered the development of new imaging technologies that have had real clinical impact. For instance, through the development of ultra-rapid imaging it was possible to almost triple the number of cardiac MRI scans performed at GOSH with no increase in staff or infrastructure. Recently, he has been at the forefront of developing Machine Learning (ML) techniques to further speed up MRI, reduce post-processing burden, massively accelerate computational fluid dynamics, and enable autonomous robotic catheterisation. Professor Muthurangu is also the programme director of the 4-year BHF PhD programme at UCL.

Rick Nishimura

Rick A. Nishimura, M.D., was a consultant in the Division of Structural Heart Disease, Department of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota, with a joint appointment in the Division of Interventional Cardiology. He joined the staff of Mayo Clinic in 1983 and holds the academic rank of professor of medicine, Mayo Clinic College of Medicine and Science. Dr. Nishimura is recognized with the distinction of the Judd and Mary Morris Leighton Professorship in Cardiovascular Diseases and Hypertension.

Dr. Nishimura went to Knox College for his undergraduate degree, subsequently receiving his medical degree from Rush Medical College. He then attended the Mayo Graduate School of Medicine (now Mayo Clinic Graduate School of Biomedical Sciences) for his internship, residency and cardiovascular fellowship.

Dr. Nishimura's practice in the field of cardiovascular diseases included subspecialty interests in cardiac hemodynamic valvular heart disease, hypertrophic cardiomyopathy and pericardial disease. He received referrals from cardiologists all over the country to consult in difficult diagnostic cases. Aside from patient care, he also worked in the Cardiac Echocardiography and Catheterization Laboratories, specializing in hemodynamics and structural heart disease. Dr. Nishimura has written over 500 manuscripts and 50 book chapters in the field of cardiovascular diseases. He has served on editorial boards for prominent medical journals and has been a distinguished visiting professor at multiple academic centers. He is a recipient of the Plummer Distinguished Clinician Award and the Mayo Clinic Distinguished Clinician Award, as well as the Presidential Citation from the American College of Cardiology.

Dr. Nishimura also served as the Terrance D. and Judith A. Paul Director of MayoExpert. In this role, he led an institutional effort to provide the optimal Mayo Clinic-vetted knowledge to Mayo physicians through electronic systems to be used at the point of care. He formed the Mayo Clinic Knowledge Management Program with the goal of enhancing patient care through digital solutions.

Dr. Nishimura has a passion for education and was involved in educating medical students, fellows and practicing cardiologists, both at Mayo Clinic and through numerous medical meetings. He has been honored multiple times as Outstanding Cardiovascular Diseases Teacher and Teacher of the Year, with induction into the Hall of Fame. He has also been recognized with the Mayo Clinic Distinguished Educator Award; the Gifted Teacher Award, conferred by the American College of Cardiology; and the Laennec Award for Clinician Educator, conferred by the American Heart Association.

Dr. Nishimura was active in the American College of Cardiology and the American Heart Association, having served on the Board of Trustees and was the Chair of multiple ACC educational committees.  He has been on several national guideline writing committees and chaired the ACC/AHA Guidelines on the Management of Valvular Heart Disease.

Patrick O'Gara

Patrick T. O'Gara, MD, MACC, FAHA, FESC, is the Watkins Family Distinguished Chair in Cardiology at Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School. He is active in the clinical and educational programs of the Cardiovascular Division at BWH and maintains an active ambulatory referral practice. O'Gara has served in several leadership roles for the American College of Cardiology (ACC) and American Heart Association (AHA) including as ACC President in 2014-15, Chair of the AHA/ACC Joint Committee on Clinical Practice Guidelines 2019-2021, and Chair of the AHA Council on Clinical Cardiology 2003-2005. He is Editor-in-Chief of the ACC Self-Assessment Programs and past Director of the ACC Board Course. O’Gara chaired the writing committee for the 2013 ACC/AHA Guideline for the Management of Patients with ST-Elevation MI and has participated as a writing committee member for several other guideline documents (Valvular Heart Disease, Radionuclide Imaging, Dual Anti-Platelet Therapy), expert consensus/scientific advisory statements, and appropriate use criteria. O’Gara is Deputy Editor for JAMA Cardiology and a member of the Editorial Boards of the Journal of the American College of Cardiology and Circulation. He is senior investigator and Chair of the Publications Committee for the NHLBI Cardiothoracic Surgery Trial Network and a member of the Heart Valve Collaboratory Executive Committee. 

Maurizio Taramasso

Specialist in cardiac surgery since 2014, Dr Maurizio Taramasso has completed his surgical training at the San Raffaele University Hospital in Milan, Italy. He has also done specific cross-training in interventional cardiology and heart valve transcatheter therapies (mitral and aortic) at the San Raffaele University Hospital. His main areas of interest include surgical and catheter treatments of valvular heart disease (transfemoral and transapical TAVI, MitraClip) and heart failure. He is author and co-author of numerous publications on this topic. 

Carol Warnes

Dr. Carole Warnes is an Emeritus Professor in the Department of Cardiovascular Medicine and Pediatric Cardiology at Mayo Clinic-Rochester, Minnesota, United States.

She received her medical degree from Newcastle upon Tyne University in England and then pursued cardiology training in London.  She completed a postgraduate thesis at the National Institutes of Health (NIH) before returning to the National Heart Hospital in London for another two years as a British Heart Foundation Scholar.  She joined the Department of Cardiovascular Diseases at Mayo Clinic in 1987, where she founded the Adult Congenital Heart Disease (ACHD) Clinic. 

At Mayo, she received the Henry S. Plummer Distinguished Physician Award in 2004 and the Distinguished Educator Award in 2010.  She remains passionate about education and has trained about 30 fellows in ACHD, with many of them now leading ACHD practices around the world. She has received the Cardiovascular Teacher of the Year 8 times and in 2014 Mayo awarded her the Lifetime Achievement for Outstanding Contributions to Medical Education. 

In 2015, she received the Laennec Master Clinician Award from the American Heart Association (AHA) and in 2016 she was honored with the Distinguished Fellow Award from the American College of Cardiology (ACC), where she had served on the Board of Trustees for 7 years.  In 2018, she received the Lifetime Achievement Award from the International Society for Adult Congenital Heart Disease (ISACHD), and in 2021 received the Mayo Distinguished Alumni Award.

Her research interests include the long-term outcomes of ACHD patients and the management of pregnancy and heart disease.  She Chaired the first ACC/AHA Guidelines for the Management of ACHD, has edited three books, and published over 200 manuscripts.


Nathan Wong 

Dr. Nathan Wong, PhD, MPH, FACC, FAHA, FNLA, MASPC, is a cardiovascular epidemiologist, specialist in preventive cardiology, and Professor and Director, Heart Disease Prevention Program, Division of Cardiology at the University of California, Irvine with joint appointments in epidemiology at UC Irvine and UCLA and population health and disease prevention at UC Irvine. He holds MPH and PhD degrees in epidemiology from Yale University and is a fellow of the American College of Cardiology, American Heart Association, National Lipid Association (NLA), and master of the American Society for Preventive Cardiology (ASPC).  He is a past president of the ASPC, Pacific Lipid Association chapter of the NLA, and the InterAmerican Heart. 

 Dr. Wong’s research interests include subclinical atherosclerosis, where he did pioneering work on coronary calcium beginning over 30 years ago, and the epidemiology and management of dyslipidemia, diabetes, and obesity in relation to cardiovascular disease, including research on residual dyslipidemia and cardiovascular disease prevention.  He has been an investigator or collaborator for many years with the NIH sponsored Framingham Heart Study, Multiethnic Study of Atherosclerosis and other large-scale studies and was a co-principal investigator at UC Irvine for the Women’s Health Initiative.  He has been an investigator for numerous clinical trials including the Antihypertensive Lipid-Lowering to Prevent Heart Attack Trial (ALLHAT) as well as early statin and more recent non-statin clinical trials.  He has authored over 400 peer-reviewed manuscripts, co-edited seven textbooks, and is on the editorial board of several cardiology and diabetes-related journals, including serving as co-editor-in-chief of the American Journal of Preventive Cardiology, guest editor-in-chief of JACC Asia and cardiovascular medicine editor-in-chief of the Journal of Clinical Medicine.  He is a recipient of the ASPC Joseph Stokes Award for lifetime achievement in preventive cardiology and lifetime achievement award in clinical research from the UC Irvine School of Medicine.


National Faculty

  • Agatha Kwon
  • Andre La Gerche
  • Andrew MacIsaac
  • Bec Perry
  • Belinda Gray
  • Bianca Coelho
  • Bonita Anderson
  • Cathy West
  • Christian Hamilton-Craig
  • Clara Chow
  • Constantine Aroney
  • Darryl Burstow
  • David Colquhoun
  • David Platts
  • David Playford
  • David Prior
  • David Whalley
  • Gemma Figtree
  • Grant King
  • Greg Cranney
  • Greg Scalia
  • Hari Raju
  • Homayoun Jalali
  • Jason Sharp
  • Jeremy  Richmond
  • Jo-Dee Lattimore
  • John Atherton 
  • Julia Isbister
  • Julie Humphries
  • Karam Kostner
  • kate sturwohld
  • Laura Fong
  • Leonard Kritharides
  • Liza Thomas
  • Martin Ng
  • Martin Ugander
  • Natalie Edwards
  • Peter Tesar
  • Rachael Cordina
  • Rajesh Puranik
  • Ravinay Bhindi
  • Rebecca Kozor
  • Stuart Moir
  • Tony Forshaw
  • Warwick Bishop